Status:

RECRUITING

Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)

Lead Sponsor:

University of Eastern Piedmont

Conditions:

Early Breast Cancer

Neoadjuvant Treatment

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

NEOMET is an exploratory randomized prospective, multicenter study whose primary aim is to explore if metabolomic signatures can be modified by a lifestyle intervention including dietary supplements a...

Detailed Description

The primary objectives are: 1. To explore the impact of a lifestyle intervention including dietary supplements and physical exercise on the modulation of metabolomic signatures in eBC patients candida...

Eligibility Criteria

Inclusion

  • \- Women (regardless of menopausal status) ≥ 18 years of age
  • Pathologic confirmation of breast cancer by tumor biopsy
  • Immunohistochemical assessment (as per local standards) of ER and PgR status, HER2 status;
  • Stage I-III breast cancer without evidence of distant metastases
  • Being candidate to standard neoadjuvant therapy
  • Having available tumor tissue from breast and/or lymph node at baseline
  • Ability to fill a nutritional daily diary
  • Medical clearance for non-agonistic physical activity
  • Written informed consent to study-specific procedures

Exclusion

  • \- locally advanced or inflammatory or stage IV BC;
  • tumor size \< 1 cm with negative nodes (pT1a, N0);
  • chronic diseases or orthopedic issues that might interfere with ability to undertake a dietary and physical activity program;
  • personal history of eating disorders.
  • women engaged in agonistic/vigorous sport activities, not able to be compliant to exercise schedules

Key Trial Info

Start Date :

September 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT06928701

Start Date

September 1 2024

End Date

December 1 2026

Last Update

April 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AOU Maggiore della Carità

Novara, Novara, Italy, 28100